Targeting Jurkat T Lymphocyte Leukemia Cells by an Engineered Interferon-Alpha Hybrid Molecule. [electronic resource]
Producer: 20170804Description: 519-529 p. digitalISSN:- 1421-9778
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Apoptosis -- drug effects
- Cell Line, Tumor
- Genes, Synthetic -- genetics
- Genetic Engineering
- Humans
- Interferon-alpha -- administration & dosage
- Jurkat Cells
- Leukemia-Lymphoma, Adult T-Cell -- genetics
- Peptide Library
- Peptides -- administration & dosage
- STAT1 Transcription Factor -- biosynthesis
- T-Lymphocytes -- drug effects
- Zidovudine -- administration & dosage
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.